〔1〕 张辉,贾雷,姚士伟,等.MELD-Na评分对我国HBV相关慢加急性肝衰竭短期预后预测价值的Meta分析〔J〕.临床肝胆病杂志,2018,34(9):1950-1955.
〔2〕 朱萍,刘华,叶青,等.重症酒精性肝炎的研究进展〔J〕.武警后勤学院学报(医学版),2020,29(3):66-71.
〔3〕 中华医学会,中华医学会杂志社,中华医学会消化病学分会,等.酒精性肝病基层诊疗指南(2019年)〔J〕.中华全科医师杂志,2020,19(11):990-996.
〔4〕 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)〔J〕.临床肝胆病杂志,2019,35(1):38-44.
〔5〕 NAMACHIVAYAM A, VALSALA GOPALAKRISHNAN A. A Review
on Molecular Mechanism of Alcoholic Liver Disease〔J〕. Life Sci,2021,274:119328.
〔6〕 杨玲玲,李君.乙型肝炎相关慢加急性肝衰竭诊断与预后评估的中国标准〔J〕.中华临床感染病杂志,2019,12(1):22-23.
〔7〕 张雪云,应悦,刘小琴,等.基于终末期肝病评分模型对91例乙型肝炎病毒相关性慢加急肝衰竭患者预后的评估及死亡危险因素分析〔J〕.微生物与感染,2019,14(1):8-15.
〔8〕 WU D, SUN Z, LIU X, et al. HINT: A Novel Prognostic Model for
Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure〔J〕. Aliment Pharmacol Ther,2018,48(7):750-760.
〔9〕 付鑫,丁芳,卢建华,等.乙型肝炎病毒相关慢加急性肝衰竭的危险因素及其风险预测模型〔J〕.中华疾病控制杂志,2021,25(7):864-868.
〔10〕 OSNA N A, DONOHUE T M, KHARBANDA K K. Alcoholic Liver
Disease: Pathogenesis
and Current Management〔J〕. Alcohol Res,2017,38(2):147-161.
〔11〕 MARGOLES L M, MITTAL R, KLINGENSMITH N J, et al.
Chronic Alcohol Ingestion Delays T Cell
Activation and Effector Function in Sepsis〔J〕. PLoS One,2016,11(11):e0165886.
〔12〕 许影,赵金明,张飞宇,等.酒精性肝病合并脓毒症的研究进展〔J〕.中华全科医师杂志,2020,19(8):748-752.
〔13〕 RUI F, YANG H, GUO Z, et al. Derivation and Validation
of Prognostic Models for Predicting Survival Outcomes in Acute-on-Chronic Liver
Failure Patients〔J〕. J Viral Hepat,2021,28(12):1719-1728.
〔14〕 CAI J, WANG K, HAN T, et al. Evaluation of Prognostic
Values of Inflammation-Based Makers in Patients with HBV-Related
Acute-on-Chronic Liver Failure〔J〕. Medicine (Baltimore),2018,97(46):e13324.
〔15〕 吴杜娟,金蕾,郜玉峰,等.中性粒细胞与淋巴细胞比值对慢加急性肝衰竭患者短期预后的评估价值〔J〕.临床肝胆病杂志,2018,34(9):1945-1949.
〔16〕 强丽,秦娇,孙长峰,等.基于炎症因子中性粒/淋巴细胞比值与红细胞分布宽度的预测模型对乙肝相关慢加急性肝衰竭的预后评估〔J〕.重庆医科大学学报,2021,46(3):317-324.
〔17〕 刘晨瑞,李亚萍,罗森,等.HBV相关慢加急性肝衰竭患者短期预后的影响因素分析〔J〕.临床肝胆病杂志,2021,37(1):56-62.
〔18〕 MALINCHOC M, KAMATH P S, GORDON F D, et al. A Model to Predict Poor
Survival in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunts〔J〕. Hepa-tology,2000,31(4):864-871.
〔19〕 FONCEA C G, SPOREA I, LUPU ORU R, et al. Day-4 Lille Score Is a Good
Prognostic Factor and Early Predictor in Assessing Therapy Response in Patients
with Liver Cirrhosis and Severe Alcoholic Hepatitis〔J〕. J Clin Med,2021,10(11):2338.
|